Illustration of antibody molecules interacting with botulinum toxin protein representing immunogenicity and toxin resistance concept

Botulinum Toxin Resistance and Antibody Formation: Clinical Implications

This guide covers the clinical science of botulinum toxin resistance: what causes it, how to distinguish true immunological non-response from pseudo-resistance, which products carry the lowest immunogenicity risk, and how to manage patients who have developed or are developing resistance. It is one of the most clinically important topics in long-term toxin practice, and one that becomes increasingly relevant as patient treatment histories lengthen.